Novartis arthritis drug fails to help COVID-19 patients – Reuters UK

Novartis arthritis drug fails to help COVID-19 patients – Reuters UK

Novartis’s canakinumab failed to help COVID-19 patients survive without invasive ventilation compared with standard therapy, the Swiss drugmaker said on Friday, dashing hopes the arthritis drug could be repurposed during the pandemic.

Read More…

You May Also Like